EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unveiling the UFMylation Pathway: Implications in Neurodegenerative Diseases

Yi-Rong Dong, Jin-Rong Wang, Yang Yang, Qiu-Zhu Chen, Yue-Qi Jiang, Xing Yang, Mei-Chuan Zhou, Shou-Peng Cao, Sen-Xiang Zeng, Cai-Xia Zang, Fang-Fang Li, Xiu-Qi Bao und 1 weitere

Journal of Molecular Biology · 2026-06 · 438 (12) · 169772

DOI: 10.1016/j.jmb.2026.169772 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Molecular Biology, 2026-06. Verfasst von Yi-Rong Dong und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Pharmacology, Institute of Materia Medica, Chinese Acade…. Hauptthemen laut MEDLINE: Neurodegenerative Diseases, Protein Processing, Post-Translational, Proteins. Die Arbeit nennt 91 Literaturangaben. Gefördert von: Natural Science Foundation of Beijing Municipality, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

UFMylation is a recently characterized post-translational modification (PTM) system that conjugates Ubiquitin-Fold Modifier 1 (UFM1) to target proteins via a dedicated enzymatic cascade. This modification system regulates critical cellular processes by controlling protein subcellular localization, modulating protein-protein interactions, and coordinating with ubiquitination to regulate protein stability. Emerging evidence highlights UFMylation as a critical modifier of pathological proteins, including tau and α-synuclein, while impaired UFMylation pathways are observed in the brains of individuals with neurodegenerative disorders. In this review, we summarize the current role and mechanism of UFMylation in the pathogenesis of neurodegenerative diseases, offering the first comprehensive framework for targeting UFMylation in the treatment of neurodegenerative diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurodegenerative DiseasesProtein Processing, Post-TranslationalProteinsHumansUbiquitinationAnimalsalpha-Synucleintau Proteins

Stichwörter der Autor:innen

Alzheimer’s diseaseParkinson’s diseaseUFMylationamyotrophic lateral sclerosistargeted therapy

Substanzen

alpha-SynucleinUFM1 protein, humantau ProteinsProteins

Autor:innen und Institutionen

  • State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Department of Pharmacology, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, 1 Xian Nong Tan…

Förderung

  • Natural Science Foundation of Beijing Municipality
  • National Natural Science Foundation of China

Zitieren

APA

Dong, Y. R., Wang, J. R., Yang, Y., Chen, Q. Z., Jiang, Y. Q., Yang, X., Zhou, M. C., Cao, S. P., Zeng, S. X., Zang, C. X., Li, F. F., Bao, X. Q., & Zhang, D. (2026). Unveiling the UFMylation Pathway: Implications in Neurodegenerative Diseases. Journal of Molecular Biology, 438(12), 169772. https://doi.org/10.1016/j.jmb.2026.169772

Vancouver

Dong YR, Wang JR, Yang Y, Chen QZ, Jiang YQ, Yang X, et al. Unveiling the UFMylation Pathway: Implications in Neurodegenerative Diseases. Journal of Molecular Biology. 2026;438(12):169772. doi:10.1016/j.jmb.2026.169772

BibTeX
@article{Dong2026,
  author = {Dong, Yi-Rong and Wang, Jin-Rong and Yang, Yang and Chen, Qiu-Zhu and Jiang, Yue-Qi and Yang, Xing and Zhou, Mei-Chuan and Cao, Shou-Peng and Zeng, Sen-Xiang and Zang, Cai-Xia and Li, Fang-Fang and Bao, Xiu-Qi and Zhang, Dan},
  title = {Unveiling the UFMylation Pathway: Implications in Neurodegenerative Diseases},
  journal = {Journal of Molecular Biology},
  year = {2026},
  volume = {438},
  number = {12},
  pages = {169772},
  doi = {10.1016/j.jmb.2026.169772}
}
Kostenlos starten →